Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
02/2012
02/29/2012CN102365092A Burdock fruit extract containing arctigenin at high content and process for producing same
02/29/2012CN102365086A Composition for alleviating ultraviolet radiation-induced damage
02/29/2012CN102363780A Targeted human CD147 small molecule RNA interference sequence and use thereof
02/29/2012CN102363622A Compound and preparation method and use thereof
02/29/2012CN102363619A Water soluble protoporphyrin compound and preparation method and use thereof
02/29/2012CN102363618A Novel inhibitor of epidermal growth factor receptor (EGFR) and application thereof
02/29/2012CN102363023A Chinese medicinal composition for treating leukemia
02/29/2012CN102363019A Curcuma zedoary oil extract, preparation method thereof and purpose thereof
02/29/2012CN102362967A Chinese herbal medicine for treating lung cancer
02/29/2012CN102362946A Chinese herbal medicine for treating colorectal cancer
02/29/2012CN102362929A Chinese medicinal composition and extract for treating cancer ischemia, and preparation method and formulation of Chinese medicinal extract
02/29/2012CN102362899A Medicine for treating esophageal cancer
02/29/2012CN102362876A Chinese redwood bark extract, preparation method thereof and purpose thereof
02/29/2012CN102133378B Medicament for treating breast cancer
02/29/2012CN102120032B Water-soluble substrate suitable for preparing water-soluble preparations of bleomycin and homologues thereof
02/29/2012CN102068636B Herbal preparation for treating ascitic type liver cancer
02/29/2012CN102028831B Traditional Chinese medicine composition for treating tumors or cancers and preparation method thereof
02/29/2012CN102028712B Method for preparing enteric capsules by taking leech as raw material
02/29/2012CN101927001B Method for loading anti-cancer drug based on multifunctional polyamidoamine dendrimer
02/29/2012CN101921313B Polypeptide for curing or preventing cancer or derivative product and application thereof
02/29/2012CN101857860B Application of viral nucleic acid sequence strictly conservative area as siRNA design template
02/29/2012CN101829326B Use of microbubbles with high-intensity cavitation generated by combining ultrasonic in preparation of anti-tumor neovascularization medicaments
02/29/2012CN101798336B Anti-tumour compound with tracking function
02/29/2012CN101759882B Sephadex magnetic composite particles and preparation and use thereof
02/29/2012CN101745052B Medicament for treating tumors and preparation method thereof
02/29/2012CN101732235B Method for preparing solid dispersion of tamoxifen citrate
02/29/2012CN101671319B Taxus nontoxic extract process
02/29/2012CN101670100B Tolerogenic tumor-cell antigen-loaded dendritic cell, preparation method and application thereof
02/29/2012CN101601695B Self-microemulsion nanometer composition of ganodenic acid extract and preparation method thereof
02/29/2012CN101570575B Sncg monoclonal antibody and application thereof
02/29/2012CN101543585B Chinese medicament for controlling and treating skin cancer
02/29/2012CN101375936B Anti-tumor compound cherimoya formulation and preparation method thereof
02/29/2012CN101346380B Pyrimidine derivatives for the treatment of abnormal cell growth
02/29/2012CN101323649B Method for extracting mushroom polysaccharide by using ultra-high pressure
02/29/2012CN101317820B Biological endophilic ligand numerator mediated target liposome, preparation and uses thereof
02/29/2012CN101259287B Application of LDP protein as tumor target medicine guiding carrier
02/29/2012CN101125855B Method for separating hemporfin isomer and separated isomer
02/29/2012CN101049449B Composition of Chinese traditional medicine for malignant tumor
02/29/2012CN101007056B An antitumor medicinal composition and its preparation method
02/28/2012US8124759 Inhibitors of protein kinases
02/28/2012US8124728 CA125 gene and its use for diagnostic and therapeutic interventions
02/28/2012US8124650 Antitumor combinations containing taxane derivatives and epidophyllotoxins
02/28/2012US8124646 Substituted isoindoline-1,3-dione derivatives
02/28/2012US8124638 Tricyclic compounds useful as angiotensin II agonists
02/28/2012US8124614 Steroidal compounds for inhibiting steroid sulphatase
02/28/2012US8124590 Biodegradable immunomodulatory formulations and methods for use thereof
02/28/2012US8124378 Murine zcytor17 ligand polynucleotides
02/28/2012US8124134 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from Acacia
02/28/2012US8124118 Composition comprising biodegradable hydrating ceramics for controlled drug delivery
02/28/2012US8124083 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells
02/28/2012US8124081 Using amyloid A specific immunoglobulin for use in prevention and treatment of infection, nervous system, cell proliferative and inflammatory disorders
02/28/2012US8124078 Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies
02/28/2012US8124066 Methods of using interleukin-2 mutants with reduced toxicity
02/28/2012US8124057 Propellant-based nanoparticulate dry powder aerosols and method of making
02/28/2012US8124051 Peptide, oligonucleotide suppressor of antiapoptotic cellular defense and anti-tumor agent covalently attached to same carrier peptide via bi-functional water-soluble polymer, so there is simultaneous uptake of suppressor and anti-tumor agent by tumor cells
02/28/2012CA2392202C Constructs for delivery of therapeutic agents to neuronal cells
02/23/2012WO2012024659A2 Antibody-based constructs directed against tyrosine kinase receptors
02/23/2012WO2012024620A2 Autotaxin inhibitors and uses thereof
02/23/2012WO2012024559A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
02/23/2012WO2012024530A2 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
02/23/2012WO2012024350A2 Anti-cancer adenoviruses
02/23/2012WO2012024284A1 Lipidated immune response modifier compound compositions, formulations, and methods
02/23/2012WO2012024282A2 1,5-diphenyl-penta-1,4-dien-3-one compounds
02/23/2012WO2012024223A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases
02/23/2012WO2012024196A2 A novel method for creating, suspending and stabilizing electronically modified reaction intermideates
02/23/2012WO2012024150A1 Oxadiazole inhibitors of leukotriene production
02/23/2012WO2012024083A1 Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
02/23/2012WO2012023811A2 Pharmaceutical composition for suppressing angiogenesis, and method for screening active material for suppressing angiogenesis
02/23/2012WO2012023631A1 Pharmaceutical composition for inhibiting proliferation of cancer cells which comprises heat shock protein (hsp) and eci301 polypeptide, and cancer treatment method using same
02/23/2012WO2012023597A1 Composition containing tetracyclic compound
02/23/2012WO2012023345A1 Method and composition for treating, preventing and diagnosing cancer containing cancer stem cells or derived therefrom
02/23/2012WO2012023287A1 Suv420h1 and suv420h2 as target genes for cancer therapy and diagnosis
02/23/2012WO2012023286A1 Lrrc42 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023285A1 Ehmt2 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023284A1 Lhx4 as a target gene for cancer therapy and diagnosis
02/23/2012WO2012023254A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid
02/23/2012WO2012022985A1 Combined use of fc gamma riib (cd32b) and cd20 - specific antibodies
02/23/2012WO2012022948A1 Treatment of liver cancer
02/23/2012WO2012022932A1 Process for producing radiohalogenated bioconjugates and products thereof
02/23/2012WO2012022814A1 Antibodies for epidermal growth factor receptor 3 (her3)
02/23/2012WO2012022724A1 Combination anti - cancer therapy
02/23/2012WO2012022707A1 Substituted heteroaryl spiropyrrolidine mdm2 antagonists
02/23/2012WO2012022677A2 Novel combination therapy for the treatment of cancer
02/23/2012WO2012022495A1 Oncolytic measles virus
02/23/2012WO2012022408A1 Pyrimidine derivatives as fak inhibitors
02/23/2012WO2012022265A1 Pyrrolopyrimidine compounds and uses thereof
02/23/2012WO2012021981A1 Novel phytochemicals from extracts of maple syrups and maple trees and uses thereof
02/23/2012WO2012021963A1 Novel sulfonamide compounds for inhibition of metastatic tumor growth
02/23/2012WO2012021934A1 Humanized anti-interleukin 3 receptor alpha chain antibodies
02/23/2012WO2011163533A3 One step removal of selected molecules from body fluid and tissue
02/23/2012WO2011139738A9 Therapies using zanolimumab to enhance the immune response
02/23/2012WO2011134679A3 Selected plant extracts for the treatment of inflammatory diseases
02/23/2012WO2011130486A9 Combination treatments and formulations for cancer
02/23/2012WO2011130429A9 Methods and materials for treating lung cancer
02/23/2012WO2011130164A3 Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
02/23/2012WO2011123683A3 Protease activated cytokines
02/23/2012WO2011119894A3 Heterocyclic compounds useful for kinase inhibition
02/23/2012WO2011115513A3 A cytosine analogue, a method of preparation of a cytosine analogue, a dna methyltransferase 1 inhibitor, a method for dna methylation inhibition, the use of the analogue in the treatment of diseases associated with deviations from normal dna methylation
02/23/2012WO2011113047A3 Compositions and methods for characterizing breast cancer
02/23/2012WO2011112919A3 A novel method for delivery and use of isothiocyanates for prophylaxis and/or therapy of bladder cancer
1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 2211